Enzymes

Clinical Chemistry: Principles, Techniques, and Correlations: Seventh Edition

Volumn , Issue , 2013, Pages 262-291

  Johnson Davis, Kamisha L ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Activation energy; Activators; Apoenzyme; Coenzyme; Cofactor; Enzyme; Enzyme substrate (ES) complex; First order kinetics; Holoenzyme; Hydrolase; International unit (IU); Isoenzyme; Isoform; Kinetic assay; LD flipped pattern; Michaelis Menten constant; Oxidoreductase; Transferase; Zero order kinetics; Zymogen

Indexed keywords

EID: 84973863181     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (43)

1. Enzyme Nomenclature 1978. Recommendations of the Nomenclature Committee of the International Union of Biochemistry on the Nomenclature and Classification of Enzymes. New York, NY: Academic Press; 1979.
2. Baron DN, Moss DW, Walker PG, et al. Abbreviations for names of enzymes of diagnostic importance. J Clin Pathol. 1971;24:656.
3. Baron DN, Moss DW, Walker PG, et al. Revised list of abbreviations for names of enzymes of diagnostic importance. J Clin Pathol. 1975;28:592.
4. Rej R. Accurate enzyme measurements. Arch Pathol Lab Med. 1998;117:352.
5. Spitzer M, Pinto A. Early diagnosis of ectopic pregnancy: can we do it accurately using a chemical profile? J Women's Health Gender Based Med. 2000;9:537.
6. Nakafusa J, Misago N, Miura Y, Kayaba M, Tanaka T, Narisawa Y. The importance of serum creatine phosphokinase levels in the early diagnosis, and as a prognostic factor, of Vibrio vulnificus infection. Br J Dermatol. 2001;145:280-284.
7. Galen RS. The enzyme diagnosis of myocardial infarction. Hum Pathol. 1975;6:141.
8. Wilkinson JH. The Principles and Practice of Diagnostic Enzymology. Chicago, IL: Year Book Medical Publishers; 1976:395.
9. Silverman LM, Dermer GB, Zweig MH, et al. Creatine kinase BB: a new tumor-associated marker. Clin Chem. 1979;25:1432.
10. Lang H, ed. Creatine Kinase Isoenzymes: Pathophysiology and Clinical Application. Berlin, Germany: Springer-Verlag; 1981.
11. Irvin RG, Cobb FR, Roe CR. Acute myocardial infarction and MB creatine phosphokinase: relationship between onset of symptoms of infarction and appearance and disappearance of enzyme. Arch Intern Med. 1980;140:329.
12. Bark CJ. Mitochondrial creatine kinase-a poor prognostic sign. JAMA. 1980;243:2058.
13. Batsakis J, Savory J, eds. Creatine kinase. Crit Rev Clin Lab Sci. 1982;16:291.
14. Lang H, Wurzburg U. Creatine kinase, an enzyme of many forms. Clin Chem. 1982;28:1439.
15. Lott JA. Electrophoretic CK and LDH isoenzyme assays in myocardial infarction. Lab Manage. February 1983;2:23.
16. Pesce MA. The CK isoenzymes: findings and their meaning. Lab Manage. October 1982;20:25-37.
17. Roche Diagnostics. Isomune-CK Package Insert. Nutley, NJ: Hoffman-La Roche; 1979.
18. Faulkner WR, Meites S, eds. Selected Methods for the Small Clinical Chemistry Laboratory: Selected Methods of Clinical Chemistry. Vol. 9. Washington, DC: American Association for Clinical Chemistry; 1982:475.
19. Lott JA, Stang JM. Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis. Clin Chem. 1980;26:1241.
20. Leung FY, Henderson AR. Influence of hemolysis on the serum lactate dehydrogenase-1/lactate dehydrogenase-2 ratio as determined by an accurate thin-layer agarose electrophoresis procedure. Clin Chem. 1981;27:1708.
21. Bhagavan NV, Darm JR, Scottolini AG. A sixth lactate dehydrogenase isoenzyme (LDH-6) and its significance. Arch Pathol Lab Med. 1982;106:521.
22. Cabello B, Lubin J, Rywlin AM, et al. Significance of a sixth lactate dehydrogenase isoenzyme (LDH6). Am J Clin Pathol. 1980;73:253.
23. Goldberg DM, Werner M, eds. LDH-6, A Sign of Impending Death from Heart Failure, Selected Topics in Clinical Enzymology. New York, NY: Walter de Gruyter; 1983:347.
24. Posen S, Doherty E. The measurement of serum alkaline phosphatase in clinical medicine. Adv Clin Chem. 1981;22:165.
25. Warren BM. The Isoenzymes of Alkaline Phosphatase. Beaumont, TX: Helena Laboratories; 1981.
26. Fleisher GA, Eickelberg ES, Elveback LR. Alkaline phosphatase activity in the plasma of children and adolescents. Clin Chem. 1977;23:469.
27. Gittes RF. Carcinoma of the prostate. N Engl J Med. 1991;324:236.
28. Gittes RF. Prostate specific antigen. N Engl J Med. 1987;318:954.
29. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol. 1991;145:907.
30. Griffiths JC. The laboratory diagnosis of prostatic adenocarcinoma. Crit Rev Clin Lab Sci. 1983;19:187.
31. Lantz RK, Berg MJ. From clinic to court: acid phosphatase testing. Diagn Med. 1981;March/April:55.
32. Yam LT. Clinical significance of the human acid phosphatases. A review. Am J Med. 1974;56:604.
33. Rosalki SB. Gamma-glutamyl transpeptidase. Adv Clin Chem. 1975;17:53.
34. Salt WB II, Schenker S. Amylase: its clinical significance. A review of the literature. Medicine. 1976;4:269.
35. Murthy UK, DeGregorio F, Oates RP, Blair DC. Hyperamylasemia in patients with acquired immunodeficiency syndrome. Am J Gastroenterol. 1992;87:332.
36. Remaley AT, Wilding P. Macroenzymes: biochemical characterization, clinical significance, and laboratory detection. Clin Chem. 1989;35:2261-2270.
37. Turecky L. Macroenzymes and their clinical significance. Bratisl Lek Listy. 2004;105:260-263.
38. Theofilopoulous AN. Autoimmunity. In: Stites DP, Stobo JD, Wells JV, eds. Basic and Clinical Immunology. 6th ed. Norwalk, CT: Appleton & Lange; 1987:128-158.
39. Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill; 1996:11-16.
40. Wilkinson GR. Drug metabolism and variability among patients in drug response. N Engl J Med. 2005;352:2211-2221.
41. Nebert DW, Dieter MZ. The evolution of drug metabolism. Pharmacology. 2000;61:124-135.
42. Rendic S, Di Carlo FJ. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev. 1997;29:413-580.
43. McMillin GA. Pharmacogenetics fundamental of molecular diagnostics. St Louis, MO: WB Saunders; 2007:197-215.